Novo Nordisk Battles Risks from Compounded Drug Copies: Urgent Call for Regulatory Action ...Middle East

Novo Nordisk has voiced serious concerns about the safety of compounded copycat drugs mimicking its weight-loss and diabetes treatments, Wegovy and Ozempic. These unauthorized versions are linked to 10 deaths and 100 hospitalizations, raising alarm within the company.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk Battles Risks from Compounded Drug Copies: Urgent Call for Regulatory Action )

Also on site :

• Voices: I’m a Met Police whistleblower – and these are the horror stories I’ve heard
• Keir Starmer’s challenge in dealing with the G6 plus 1
• Newsom and Bass’ riot mishandling: Letters to the Editor — June 16, 2025